Animal models of exfoliation syndrome, now and future

Journal of Glaucoma

Volumn 23, Issue 8, 2014, Pages S68-S72

  John, Simon W M ^a,b,c   Harder, Jeffrey M ^b   Fingert, John H ^d   Anderson, Michael G ^d,e  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^b JACKSON LABORATORY   (United States)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF IOWA   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Alleles; Animal models; Exfoliation syndrome; Knockout mice; Transgenic mice

Indexed keywords

CAFFEINE; FIBRILLIN 1; TRANSFORMING GROWTH FACTOR BETA;

ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; CATARACT; CNTNAP2 GENE; DIET; DISEASE PREDISPOSITION; GENE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC DIFFERENCE; GENOTYPE; GLAUCOMA; HIGH SALT DIET; HIGH SUCROSE DIET; LIFESPAN; LOW TEMPERATURE; LOXL1 GENE; MOUSE; MOUSE MODEL; MOUSE MUTANT; MUTAGENESIS; NONHUMAN; OXIDATIVE STRESS; PHENOTYPE; PIGMENT EPITHELIUM; PORCINE MODEL; PRIORITY JOURNAL; PSEUDOEXFOLIATION; RADIATION EXPOSURE; VIRUS; ANIMAL; COMPLICATION; DISEASE MODEL; GENETICS; HUMAN; KNOCKOUT MOUSE; OPEN ANGLE GLAUCOMA; TRANSGENIC MOUSE;

ANIMALS; DISEASE MODELS, ANIMAL; EXFOLIATION SYNDROME; GLAUCOMA, OPEN-ANGLE; HUMANS; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC;

EID: 84923655671     PISSN: 10570829     EISSN: 1536481X     Source Type: Journal    
DOI: 10.1097/IJG.0000000000000121     Document Type: Article

References (63)

1. Schlötzer-Schrehardt U. Genetics and genomics of pseudoexfoliation syndrome/glaucoma. Middle East Afr J Ophthalmol. 2011;18:30-36.
2. Sein J, Galor A, Sheth A, et al. Exfoliation syndrome: new genetic and pathophysiologic insights. Curr Opin Ophthalmol. 2013;24:167-174.
3. Damji KF, Bains HS, Stefansson E, et al. Is pseudoexfoliation syndrome inherited? A review of genetic and nongenetic factors and a new observation. Ophthalmic Genet. 1998;19:175-185.
4. Stein JD, Pasquale LR, Talwar N, et al. Geographic and climatic factors associated with exfoliation syndrome. Arch Ophthalmol. 2011;129:1053-1060.
5. Thorleifsson G, Magnusson KP, Sulem P, et al. Common sequence variants in the LOXL1 gene confer susceptibility to exfoliation glaucoma. Science. 2007;317:1397-1400.
6. Aragon-Martin JA, Ritch R, Liebmann J, et al. Evaluation of LOXL1 gene polymorphisms in exfoliation syndrome and exfoliation glaucoma. Mol Vis. 2008;14:533-541.
7. Challa P, Schmidt S, Liu Y, et al. Analysis of LOXL1 polymorphisms in a United States population with pseudoexfoliation glaucoma. Mol Vis. 2008;14:146-149.
8. Chen L, Jia L, Wang N, et al. Evaluation of LOXL1 polymorphisms in exfoliation syndrome in a Chinese population. Mol Vis. 2009;15:2349-2357.
9. Fan BJ, Pasquale L, Grosskreutz CL, et al. DNA sequence variants in the LOXL1 gene are associated with pseudoexfoliation glaucoma in a US clinic-based population with broad ethnic diversity. BMC Med Genet. 2008;9:5.
10. Fingert JH, Alward WL, Kwon YH, et al. LOXL1 mutations are associated with exfoliation syndrome in patients from the midwestern United States. Am J Ophthalmol. 2007;144:974-975.
11. Fuse N, Miyazawa A, Nakazawa T, et al. Evaluation of LOXL1 polymorphisms in eyes with exfoliation glaucoma in Japanese. Mol Vis. 2008;14:1338-1343.
12. Hayashi H, Gotoh N, Ueda Y, et al. Lysyl oxidase-like 1 polymorphisms and exfoliation syndrome in the Japanese population. Am J Ophthalmol. 2008;145:582-585.
13. Hewitt AW, Sharma S, Burdon KP, et al. Ancestral LOXL1 variants are associated with pseudoexfoliation in Caucasian Australians but with markedly lower penetrance than in Nordic people. Hum Mol Genet. 2008;17:710-716.
14. Lee KY, Ho SL, Thalamuthu A, et al. Association of LOXL1 polymorphisms with pseudoexfoliation in the Chinese. Mol Vis. 2009;15:1120-1126.
15. Mabuchi F, Sakurada Y, Kashiwagi K, et al. Lysyl oxidaselike 1 gene polymorphisms in Japanese patients with primary open angle glaucoma and exfoliation syndrome. Mol Vis. 2008;14:1303-1308.
16. Mori K, Imai K, Matsuda A, et al. LOXL1 genetic polymorphisms are associated with exfoliation glaucoma in the Japanese population. Mol Vis. 2008;14:1037-1040.
17. Mossbock G, Renner W, Faschinger C, et al. Lysyl oxidaselike protein 1 (LOXL1) gene polymorphisms and exfoliation glaucoma in a Central European population. Mol Vis. 2008;14:857-861.
18. Ozaki M, Lee KY, Vithana EN, et al. Association of LOXL1 gene polymorphisms with pseudoexfoliation in the Japanese. Invest Ophthalmol Vis Sci. 2008;49:3976-3980.
19. Pasutto F, Krumbiegel M, Mardin CY, et al. Association of LOXL1 common sequence variants in German and Italian patients with pseudoexfoliation syndrome and pseudoexfoliation glaucoma. Invest Ophthalmol Vis Sci. 2008;49:1459-1463.
20. Ramprasad VL, George R, Soumittra N, et al. Association of non-synonymous single nucleotide polymorphisms in the LOXL1 gene with pseudoexfoliation syndrome in India. Mol Vis. 2008;14:318-322.
21. Tanito M, Minami M, Akahori M, et al. LOXL1 variants in elderly Japanese patients with exfoliation syndrome/glaucoma, primary open-angle glaucoma, normal tension glaucoma, and cataract. Mol Vis. 2008;14:1898-1905.
22. Yang X, Zabriskie NA, Hau VS, et al. Genetic association of LOXL1 gene variants and exfoliation glaucoma in a Utah cohort. Cell Cycle. 2008;7:521-524.
23. Chen H, Chen LJ, Zhang M, et al. Ethnicity-based subgroup meta-analysis of the association of LOXL1 polymorphisms with glaucoma. Mol Vis. 2010;16:167-177.
24. Krumbiegel M, Pasutto F, Schlötzer-Schrehardt U, et al. Genome-wide association study with DNA pooling identifies variants at CNTNAP2 associated with pseudoexfoliation syndrome. Eur J Hum Genet. 2011;19:186-193.
25. Malukiewicz G, Lesiewska-Junk H, Linkowska K, et al. Analysis of CNTNAP2 polymorphisms in Polish population with pseudoexfoliation syndrome. Acta Ophthalmol. 2012; 90:e660-e661.
26. Shimizu A, Takano Y, Shi D, et al. Evaluation of CNTNAP2 gene polymorphisms for exfoliation syndrome in Japanese. Mol Vis. 2012;18:1395-1401.
27. Veromann S, Sunter A, Juronen E, et al. Eye lens crystallins: a component of intraocular pseudoexfoliative material. Ophthalmic Res. 2004;36:51-54.
28. Trantow CM, Mao M, Petersen GE, et al. Lyst mutation in mice recapitulates iris defects of human exfoliation syndrome. Invest Ophthalmol Vis Sci. 2009;50:1205-1214.
29. Kenyon C. The plasticity of aging: insights from long-lived mutants. Cell. 2005;120:449-460.
30. Pasquale LR, Wiggs JL, Willett WC, et al. The Relationship between caffeine and coffee consumption and exfoliation glaucoma or glaucoma suspect: a prospective study in two cohorts. Invest Ophthalmol Vis Sci. 2012;53:6427-6433.
31. Ringvold A. Exfoliation syndrome immunological aspects. Acta Ophthalmol Suppl. 1988;184:35-43.
32. Detorakis ET, Kozobolis VP, Pallikaris IG, et al. Detection of herpes simplex virus in pseudoexfoliation syndrome and exfoliation glaucoma. Acta Ophthalmol Scand. 2002;80: 612-616.
33. Resnikoff S, Filliard G, Dell'Aquila B. Climatic droplet keratopathy, exfoliation syndrome, and cataract. Br J Ophthalmol. 1991;75:734-736.
34. Asano N, Schlötzer-Schrehardt U, Naumann GO. A histopathologic study of iris changes in pseudoexfoliation syndrome. Ophthalmology. 1995;102:1279-1290.
35. Eagle RC Jr, Font RL, Fine BS. The basement membrane exfoliation syndrome. Arch Ophthalmol. 1979;97:510-515.
36. Fingert JH, Burden JH, Wang K, et al. Circumferential iris transillumination defects in exfoliation syndrome. J Glaucoma. 2013;22:555-558.
37. Schlötzer-Schrehardt U, Naumann GO. Ocular and systemic pseudoexfoliation syndrome. Am J Ophthalmol. 2006;141: 921-937.
38. Erdurmus M, Yagci R, Atis O, et al. Antioxidant status and oxidative stress in primary open angle glaucoma and pseudoexfoliative glaucoma. Curr Eye Res. 2011;36:713-718.
39. Schlötzer-Schrehardt U, Zenkel M, Küchle M, et al. Role of transforming growth factor-beta1 and its latent form binding protein in pseudoexfoliation syndrome. Exp Eye Res. 2001;73:765-780.
40. Picht G, Welge-Luessen U, Grehn F, et al. Transforming growth factor beta 2 levels in the aqueous humor in different types of glaucoma and the relation to filtering bleb development. Graefes Arch Clin Exp Ophthalmol. 2001;239: 199-207.
41. Kottler UB, Jünemann AG, Aigner T, et al. Comparative effects of TGF-beta 1 and TGF-beta 2 on extracellular matrix production, proliferation, migration, and collagen contraction of human Tenon's capsule fibroblasts in pseudoexfoliation and primary open-angle glaucoma. Exp Eye Res. 2005;80:121-134.
42. Inatani M, Tanihara H, Katsuta H, et al. Transforming growth factor-beta 2 levels in aqueous humor of glaucomatous eyes. Graefes Arch Clin Exp Ophthalmol. 2001;239:109-113.
43. Trantow CM, Hedberg-Buenz A, Iwashita S, et al. Elevated oxidative membrane damage associated with genetic modifiers of Lyst-mutant phenotypes. PLoS Genet. 2010;6:e1001008.
44. Yilmaz A, Ayaz L, Tamer L. Selenium and pseudoexfoliation syndrome. Am J Ophthalmol. 2011;151:272-276 e271.
45. Nguyen D, Xu T. The expanding role of mouse genetics for understanding human biology and disease. Dis Model Mech. 2008;1:56-66.
46. John SW, Anderson MG, Smith RS. Mouse genetics: a tool to help unlock the mechanisms of glaucoma. J Glaucoma. 1999;8:400-412.
47. Liu X, Zhao Y, Gao J, et al. Elastic fiber homeostasis requires lysyl oxidase-like 1 protein. Nat Genet. 2004;36:178-182.
48. Wiggs JL, Pasquale LR, Pawlyk B, et al. LOXL1 null mouse phenotype suggests that loss of lysyl oxidase like 1 function contributes to exfoliation glaucoma. 59th Annual Meeting of The American Society of Human Genetics. Honolulu, HI. October 20-24, 2009.
49. Wiggs JL, Pawlyk B, Connolly E, et al. Disruption of the blood-aqueous barrier and lens abnormalities in mice lacking Lysyl Oxidase-like 1 (LOXL1). Invest Ophthalmol Vis Sci. 2014;55:856-864.
50. Zenkel M, Kruse FE, Naumann GO, et al. Impaired cytoprotective mechanisms in eyes with pseudoexfoliation syndrome/glaucoma. Invest Ophthalmol Vis Sci. 2007;48: 5558-5566.
51. Schlötzer-Schrehardt U. Oxidative stress and pseudoexfoliation glaucoma. Klin Monbl Augenheilkd. 2010;227:108-113.
52. Fleenor DL, Shepard AR, Hellberg PE, et al. TGFbeta2-induced changes in human trabecular meshwork: implications for intraocular pressure. Invest Ophthalmol Vis Sci. 2006; 47:226-234.
53. Bachmann B, Birke M, Kook D, et al. Ultrastructural and biochemical evaluation of the porcine anterior chamber perfusion model. Invest Ophthalmol Vis Sci. 2006;47: 2011-2020.
54. Shepard AR, Millar JC, Pang IH, et al. Adenoviral gene transfer of active human transforming growth factor-{beta}2 elevates intraocular pressure and reduces outflow facility in rodent eyes. Invest Ophthalmol Vis Sci. 2010;51:2067-2076.
55. Robertson JV, Golesic E, Gauldie J, et al. Ocular gene transfer of active TGF-beta induces changes in anterior segment morphology and elevated IOP in rats. Invest Ophthalmol Vis Sci. 2010;51:308-318.
56. Vreugde S, Erven A, Kros CJ, et al. Beethoven, a mouse model for dominant, progressive hearing loss DFNA36. Nat Genet. 2002;30:257-258.
57. Nair KS, Hmani-Aifa M, Ali Z, et al. Alteration of the serine protease PRSS56 causes angle-closure glaucoma in mice and posterior microphthalmia in humans and mice. Nat Genet. 2011;43:579-584.
58. Lachke SA, Alkuraya FS, Kneeland SC, et al. Mutations in the RNA granule component TDRD7 cause cataract and glaucoma. Science. 2011;331:1571-1576.
59. Beckers J, Wurst W, de Angelis MH. Towards better mouse models: enhanced genotypes, systemic phenotyping and envirotype modelling. Nat Rev Genet. 2009;10:371-380.
60. Rubio-Aliaga I, Soewarto D, Wagner S, et al. A genetic screen for modifiers of the delta1-dependent notch signaling function in the mouse. Genetics. 2007;175:1451-1463.
61. Mohan S, Baylink DJ, Srivastava AK. A chemical mutagenesis screen to identify modifier genes that interact with growth hormone and TGF-beta signaling pathways. Bone. 2008;42:388-395.
62. Matera I, Watkins-Chow DE, Loftus SK, et al. A sensitized mutagenesis screen identifies Gli3 as a modifier of Sox10 neurocristopathy. Hum Mol Genet. 2008;17:2118-2131.
63. Liu X, Dobbie M, Tunningley R, et al. ENU mutagenesis screen to establish motor phenotypes in wild-type mice and modifiers of a pre-existing motor phenotype in tau mutant mice. J Biomed Biotechnol. 2011;2011:130947.